RICHARD GAYNOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RICHARD GAYNOR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RICHARD GAYNOR. RICHARD GAYNOR is a Director in INFINITY PHARMACEUTICALS, INC. ($INFI) and a Director in Alkermes plc. ($ALKS) and a President of R&D in Neon Therapeutics, Inc. ($NTGN).
Address: C/O NEON THERAPEUTICS, INC. 40 ERIE STREET, SUITE 110 CAMBRIDGE 02139 MA
Companies in which RICHARD GAYNOR is an Insider
Alkermes plc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RICHARD GAYNOR: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 04 2020
$ALKS Market Capitalization: $8.28B
$ALKS Previous Close: $54.77
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INFINITY PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RICHARD GAYNOR: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 17 2020
$INFI Market Capitalization: $115.87M
$INFI Previous Close: $2.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Neon Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RICHARD GAYNOR: President of R&D
Holdings: 0 shares
Latest Transaction: May 06 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of RICHARD GAYNOR
Sentiment: All, ALKS, INFI, NTGN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 04 2020 | ALKS | Alkermes plc. | GAYNOR RICHARD | Director | Option Exercise | A | 0.00 | 5,578 | 0 | 5,578 | |
| Dec 04 2020 | ALKS | Alkermes plc. | GAYNOR RICHARD | Director | Option Exercise | A | 18.82 | 11,509 | 216,599 | 11,509 | |
| May 22 2020 | ALKS | Alkermes plc. | GAYNOR RICHARD | Director | Option Exercise | A | 0.00 | 6,104 | 0 | 6,104 | |
| May 22 2020 | ALKS | Alkermes plc. | GAYNOR RICHARD | Director | Option Exercise | A | 16.85 | 12,823 | 216,068 | 12,823 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | GAYNOR RICHARD | President of R&D | Option Exercise | D | 2.65 | 155,373 | 411,738 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | GAYNOR RICHARD | President of R&D | Option Exercise | D | 6.13 | 105,000 | 643,650 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | GAYNOR RICHARD | President of R&D | Option Exercise | D | 10.20 | 58,005 | 591,651 | 0 |